although βamyloid aβ may primary driver lheim disease ad pathology accueil pathology tau correct dementia patient thu preventioninhibit require vaccine target sultan sequence since high antibody tier require vaccine efficacy decide genre air aβtau b cell editor base immunogen multitep platform value immunogen formal advaxcpg delta insulin alhydrogel montanideisa plasma pharmacist grade adj formal induce highest cellular humor immune response mouse dualepitop combine robust various form molecule antiβ immune similar vaccine avravr anita significantly lower inject compare silicon model provide insight differ construct sum adj identify promise onto prelim ass future human clinic trial 